Trevi Therapeutics, Inc. (TRVI)
12.10
+0.52
(+4.49%)
USD |
NASDAQ |
Apr 02, 10:50
Trevi Therapeutics EPS Diluted (Quarterly) : -0.0572 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 0.2608 |
| Bristol Myers Squibb Co. | 0.5326 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.316M |
| Total Expenses (Quarterly) | 8.316M |
| Enterprise Value | 1.299B |
| Earnings Yield | -2.73% |
| Normalized Earnings Yield | -2.731 |